Physician profile
David A Worth
NPI 1861406902
$6,371.32
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,079 · 2020: $2,265 · 2021: $2,008 · 2022: $18.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,041.32 | 2019-2021 | |
| Abbvie INC. | $953.54 | 2019-2021 | |
| Pfizer INC. | $511.53 | 2019-2021 | |
| Janssen Biotech, INC. | $500.95 | 2019-2021 | |
| Glaxosmithkline, LLC. | $485.93 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $480.41 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $451.32 | 2019-2021 | |
| Lilly USA, LLC | $371.89 | 2019-2021 | |
| Genzyme Corporation | $307.13 | 2019-2021 | |
| Horizon Therapeutics Plc | $292.36 | 2019-2021 | |
| Ucb, INC. | $185.01 | 2020-2021 | |
| Genentech USA, INC. | $143.38 | 2019-2020 | |
| Sobi, INC | $69.91 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $68.91 | 2021 | |
| Hikma Pharmaceuticals USA | $56.33 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $55.38 | 2019 | |
| Mallinckrodt Enterprises LLC | $53.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2020 | |
| Fidia Pharma USA INC. | $48.93 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $39.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.79 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $27.67 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.44 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $25.70 | 2021 | |
| Medexus Pharma, INC. | $24.43 | 2019 | |
| Depuy Synthes Sales INC. | $22.17 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $15.11 | 2021 | |
| Radius Health, INC. | $14.79 | 2019 | |
| Zyla Life Sciences, INC. | $14.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Worth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.